Today, we present Sébastien Huynh

Conversation with women and men engaged in our foundation. Today, we present Sébastien HUYNH | LinkedIn. AC: Can you introduce your professional background? SH: My career has allowed me to develop broad skills in management, finance, and accounting. Having grown up in France, I have had the opportunity to work...

Continue reading

U.S. Food & Drug Administration Approves Reata Pharmaceuticals’ SKYCLARYS™ for the Treatment of Adults and Adolescents Aged 16 Years and Older with Freidreich Ataxia

U.S. Food & Drug Administration Approves Reata Pharmaceuticals’ SKYCLARYS™ (Omaveloxolone) for the Treatment of Adults and Adolescents Aged 16 Years and Older with FA   Montreal,QC ., February 28, 2023 – This week  marks the approval of the first medication to treat Friedreich’s Ataxia (FA), a milestone for the FA...

Continue reading